Phathom Pharmaceuticals, Inc. (PHAT)
USD 2.76
(-17.86%)
USD 2.76
(-17.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 486.6 Million USD | 103.07% |
| 2022 | 239.62 Million USD | 104.33% |
| 2021 | 117.27 Million USD | 16.3% |
| 2020 | 100.84 Million USD | 245.07% |
| 2019 | 29.22 Million USD | 1235.6% |
| 2018 | 2.18 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 505 Million USD | 3.78% |
| 2024 Q2 | 553.2 Million USD | 9.55% |
| 2023 Q4 | 486.6 Million USD | 91.0% |
| 2023 Q3 | 254.76 Million USD | 2.96% |
| 2023 FY | 486.6 Million USD | 103.07% |
| 2023 Q1 | 234.2 Million USD | -2.26% |
| 2023 Q2 | 247.43 Million USD | 5.65% |
| 2022 Q1 | 111.01 Million USD | -5.34% |
| 2022 Q4 | 239.62 Million USD | 4.94% |
| 2022 FY | 239.62 Million USD | 104.33% |
| 2022 Q3 | 228.35 Million USD | 3.56% |
| 2022 Q2 | 220.5 Million USD | 98.63% |
| 2021 Q2 | 82.45 Million USD | 0.52% |
| 2021 FY | 117.27 Million USD | 16.3% |
| 2021 Q4 | 117.27 Million USD | -6.1% |
| 2021 Q3 | 124.89 Million USD | 51.48% |
| 2021 Q1 | 82.02 Million USD | -18.66% |
| 2020 Q4 | 100.84 Million USD | 35.35% |
| 2020 Q3 | 74.5 Million USD | 16.41% |
| 2020 Q2 | 63.99 Million USD | 15.9% |
| 2020 Q1 | 55.22 Million USD | 88.96% |
| 2020 FY | 100.84 Million USD | 245.07% |
| 2019 FY | 29.22 Million USD | 1235.6% |
| 2019 Q4 | 29.22 Million USD | -87.41% |
| 2019 Q3 | 232.16 Million USD | 37.16% |
| 2019 Q1 | - USD | -100.0% |
| 2019 Q2 | 169.26 Million USD | 0.0% |
| 2018 FY | 2.18 Million USD | 0.0% |
| 2018 Q4 | 2.18 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Absci Corporation | 58.3 Million USD | -734.593% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -37.904% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 87.987% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -14984.787% |
| Apollomics, Inc. | 14.15 Million USD | -3338.147% |
| 180 Life Sciences Corp. | 5.38 Million USD | -8932.525% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -9193.373% |
| Bicycle Therapeutics plc | 224.41 Million USD | -116.834% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1668.751% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -273.705% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -852.197% |
| Chimerix, Inc. | 19.74 Million USD | -2364.426% |
| CRISPR Therapeutics AG | 346.76 Million USD | -40.325% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -145.359% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -447.598% |
| Fortress Biotech, Inc. | 165.93 Million USD | -193.241% |
| Fortress Biotech, Inc. | 165.93 Million USD | -193.241% |
| Gritstone bio, Inc. | 125.91 Million USD | -286.44% |
| Allakos Inc. | 74.79 Million USD | -550.597% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -89.357% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -607.691% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 59.806% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3262.129% |
| Innoviva, Inc. | 568.55 Million USD | 14.414% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -68923.083% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4456.102% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1750.616% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -37352.713% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -3600.388% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1877.571% |
| ImmuCell Corporation | 18.81 Million USD | -2486.236% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1623.946% |
| Incyte Corporation | 1.59 Billion USD | 69.44% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -775.256% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -120373.227% |
| Mustang Bio, Inc. | 17.61 Million USD | -2661.797% |
| MiMedx Group, Inc. | 96.33 Million USD | -405.14% |
| MEI Pharma, Inc. | 8.35 Million USD | -5724.069% |
| MacroGenics, Inc. | 154.2 Million USD | -215.551% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -27588.798% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2948.496% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -15725.205% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -215.682% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 30.243% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -470.07% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -7882.3% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -9535.663% |
| NextCure, Inc. | 14.99 Million USD | -3144.656% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1691.015% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -11938.619% |
| Onconetix, Inc. | 23.18 Million USD | -1999.147% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -7187.719% |
| Opthea Limited | 264.6 Million USD | -83.9% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -765.378% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3919.935% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1363.06% |
| Precigen, Inc. | 41.64 Million USD | -1068.478% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3981.538% |
| Prime Medicine, Inc. | 60.78 Million USD | -700.594% |
| PureTech Health plc | 125.58 Million USD | -287.474% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -559.646% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 93.153% |
| Replimune Group, Inc. | 113.21 Million USD | -329.806% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8644.12% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -233.588% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -13689.079% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -85.445% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7264.62% |
| Sesen Bio, Inc. | 30.98 Million USD | -1470.491% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -490.299% |
| Solid Biosciences Inc. | 38.45 Million USD | -1165.279% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -729.189% |
| SciSparc Ltd. | 1.59 Million USD | -30407.9% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -51.548% |
| TG Therapeutics, Inc. | 169.08 Million USD | -187.785% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -894.443% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -33598.13% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 17.259% |
| UroGen Pharma Ltd. | 243.52 Million USD | -99.817% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -686.947% |
| XOMA Corporation | 145.58 Million USD | -234.25% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -290.418% |
| AbCellera Biologics Inc. | 335.77 Million USD | -44.918% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -4878.525% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3327.975% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1283.289% |
| Precision BioSciences, Inc. | 140.92 Million USD | -245.303% |
| Dyadic International, Inc. | 2.34 Million USD | -20689.131% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -11673.554% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2892.074% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -5336.883% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1465.086% |
| IGM Biosciences, Inc. | 220.17 Million USD | -121.004% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -406.038% |
| Acelyrin, Inc. | 86.35 Million USD | -463.502% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -889.509% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -272.284% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -13689.712% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -222.489% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -221.163% |
| Senti Biosciences, Inc. | 52.57 Million USD | -825.607% |
| Mesoblast Limited | 188.79 Million USD | -157.736% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -169.156% |
| ChromaDex Corporation | 26.5 Million USD | -1735.676% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5586.456% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -78.709% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -29870.202% |
| Seer, Inc. | 39.36 Million USD | -1136.126% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -39.997% |
| Novavax, Inc. | 2.57 Billion USD | 81.083% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -6224.402% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -253.121% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2540.982% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -411.797% |
| Celcuity Inc. | 51.45 Million USD | -845.773% |
| ContextLogic Inc. | 206 Million USD | -136.214% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -580.751% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 93.644% |
| Amarin Corporation plc | 279.58 Million USD | -74.043% |
| AnaptysBio, Inc. | 364.28 Million USD | -33.577% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3755.487% |
| Aptorum Group Limited | 5.25 Million USD | -9156.71% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 34.705% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -1.716% |
| Ardelyx, Inc. | 130.76 Million USD | -272.124% |
| Celularity Inc. | 102.92 Million USD | -372.754% |
| Omeros Corporation | 403.25 Million USD | -20.669% |
| Humacyte, Inc. | 114.67 Million USD | -324.323% |
| Immunocore Holdings plc | 228.15 Million USD | -113.274% |
| IO Biotech, Inc. | 17.55 Million USD | -2671.708% |
| GT Biopharma, Inc. | 6.63 Million USD | -7236.062% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2688.225% |
| Summit Therapeutics Inc. | 125.25 Million USD | -288.482% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -24777.352% |
| Pulmatrix, Inc. | 15.96 Million USD | -2948.305% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -94.013% |
| Evogene Ltd. | 17.99 Million USD | -2604.842% |
| CorMedix Inc. | 11.91 Million USD | -3983.07% |
| BioLineRx Ltd. | 50.7 Million USD | -859.727% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -5094.844% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -8506.314% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 82.122% |
| scPharmaceuticals Inc. | 57.26 Million USD | -749.795% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2062.575% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -323.824% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4456.102% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7264.62% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -982.177% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -16854.739% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -7055.897% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -607.505% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2484.729% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -941.103% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3827.996% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1748.096% |
| bluebird bio, Inc. | 424.62 Million USD | -14.596% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 74.255% |
| DBV Technologies S.A. | 42.8 Million USD | -1036.918% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -280.779% |
| Galecto, Inc. | 5.89 Million USD | -8153.07% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -5033.463% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1673.521% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -84.047% |
| GlycoMimetics, Inc. | 6.9 Million USD | -6950.069% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -92.562% |
| ADMA Biologics, Inc. | 193.97 Million USD | -150.856% |
| Clene Inc. | 38.95 Million USD | -1149.264% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -155.752% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2978.058% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -4307.743% |
| Soligenix, Inc. | 7.27 Million USD | -6588.762% |
| Century Therapeutics, Inc. | 175.94 Million USD | -176.571% |
| Kura Oncology, Inc. | 51.66 Million USD | -841.893% |
| Surrozen, Inc. | 8.14 Million USD | -5874.23% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -301.215% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -7257.298% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -92.639% |
| Autolus Therapeutics plc | 263.9 Million USD | -84.384% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -4542.253% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -937.551% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -570.554% |
| GRI Bio, Inc. | 2.69 Million USD | -17942.306% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -60004.992% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1249.495% |
| INmune Bio, Inc. | 18.86 Million USD | -2479.795% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -89.724% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1726.456% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -17800.233% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -13467.497% |
| Jaguar Health, Inc. | 45.86 Million USD | -960.919% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -14734.193% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -732.437% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -874.566% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -83.807% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 40.877% |
| Verastem, Inc. | 71.18 Million USD | -583.572% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1161.343% |
| Histogen Inc. | 5.69 Million USD | -8441.355% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -10995.413% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -53.405% |
| Surrozen, Inc. | 8.14 Million USD | -5874.23% |
| Organovo Holdings, Inc. | 2.74 Million USD | -17607.46% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -154938.584% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -58748.193% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -283.982% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -4399.902% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -18562.701% |
| Kronos Bio, Inc. | 54.2 Million USD | -797.771% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3339.362% |
| Synaptogenix, Inc. | 5.52 Million USD | -8700.14% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -7219.51% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -114.52% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -186.054% |
| Exelixis, Inc. | 678.44 Million USD | 28.277% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -196.625% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 18.109% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3215.624% |
| ESSA Pharma Inc. | 3.49 Million USD | -13822.493% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -9462.52% |
| Avid Bioservices, Inc. | 275.66 Million USD | -76.517% |
| Insmed Incorporated | 1.66 Billion USD | 70.718% |
| MediWound Ltd. | 27.18 Million USD | -1689.83% |
| OmniAb, Inc. | 87.4 Million USD | -456.752% |
| Alector, Inc. | 487.66 Million USD | 0.219% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -20.608% |
| Zai Lab Limited | 240.17 Million USD | -102.601% |
| AlloVir, Inc. | 45.01 Million USD | -980.975% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 22.769% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1490.303% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1564.902% |
| Immunic, Inc. | 25.36 Million USD | -1818.169% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -602.815% |
| Veracyte, Inc. | 93.71 Million USD | -419.213% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -18496.172% |
| FibroGen, Inc. | 585.72 Million USD | 16.924% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2699.292% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -479.108% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -74409.092% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -8504.095% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -5835.606% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -479.135% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 81.416% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1588.297% |
| XBiotech Inc. | 8.39 Million USD | -5694.939% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3215.624% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1186.896% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3284.109% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -815.008% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -34.011% |
| Agenus Inc. | 462.29 Million USD | -5.258% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1710.002% |
| Theravance Biopharma, Inc. | 169 Million USD | -187.923% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 59.97% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 2.763% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 49.963% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -7968.187% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -273.341% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -130920.156% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -9341.175% |
| Lantern Pharma Inc. | 2.73 Million USD | -17661.222% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1045.617% |
| Ainos, Inc. | 7.39 Million USD | -6480.827% |
| Pluri Inc. | 34.11 Million USD | -1326.48% |
| Prothena Corporation plc | 135.01 Million USD | -260.4% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -100.162% |
| Rallybio Corporation | 9.43 Million USD | -5056.857% |
| Kodiak Sciences Inc. | 213.59 Million USD | -127.819% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1890.595% |
| MeiraGTx Holdings plc | 319.99 Million USD | -52.067% |
| Annexon, Inc. | 47.11 Million USD | -932.728% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -404.919% |
| Moderna, Inc. | 4.57 Billion USD | 89.357% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -9881.559% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -534.09% |
| Blueprint Medicines Corporation | 918.64 Million USD | 47.03% |
| Immix Biopharma, Inc. | 3.72 Million USD | -12974.405% |
| CalciMedica, Inc. | 4.02 Million USD | -11980.462% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -290.828% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -467.022% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -113.942% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -75.167% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2985.025% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -858.14% |
| Nutriband Inc. | 1.07 Million USD | -45000.791% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -4476.328% |
| Vor Biopharma Inc. | 59.1 Million USD | -723.296% |
| Roivant Sciences Ltd. | 773.95 Million USD | 37.128% |
| Alkermes plc | 933.53 Million USD | 47.876% |
| ProKidney Corp. | 29.21 Million USD | -1565.529% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -576.032% |
| Arcellx, Inc. | 339.75 Million USD | -43.222% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 74.239% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -225.575% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -450.198% |
| Atai Life Sciences N.V. | 49.16 Million USD | -889.791% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1462.006% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2609.058% |
| MediciNova, Inc. | 3.89 Million USD | -12404.031% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2562.077% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -32248.606% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13724.359% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -22.49% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1485.536% |
| RenovoRx, Inc. | 4.46 Million USD | -10795.678% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1459.569% |
| Geron Corporation | 146.12 Million USD | -232.999% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2454.604% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1417.688% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -559.44% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -456.223% |
| Royalty Pharma plc | 6.29 Billion USD | 92.273% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1340.927% |
| Imunon, Inc. | 8.53 Million USD | -5604.298% |
| BioAtla, Inc. | 48.98 Million USD | -893.347% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -272.577% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3323.152% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -157.249% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1574.989% |
| 89bio, Inc. | 59.96 Million USD | -711.502% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1345.421% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1440.023% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -687.087% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -905.332% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -5864.696% |
| Akari Therapeutics, Plc | 4.58 Million USD | -10515.205% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2644.022% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 70.499% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -256.958% |
| Liquidia Corporation | 73.13 Million USD | -565.319% |
| Entera Bio Ltd. | 1.37 Million USD | -35186.512% |
| GH Research PLC | 6.7 Million USD | -7161.618% |
| Vericel Corporation | 127.7 Million USD | -281.035% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1167.751% |
| Xencor, Inc. | 283.55 Million USD | -71.605% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -16197.856% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -17800.233% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -12851.419% |
| Vaxcyte, Inc. | 167.44 Million USD | -190.597% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1219.524% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -370.01% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -120373.227% |
| Portage Biotech Inc. | 4.45 Million USD | -10834.854% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -32248.606% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2011.067% |
| OncoCyte Corporation | 49.29 Million USD | -887.06% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -11662.725% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -60917.024% |
| Purple Biotech Ltd. | 10 Million USD | -4763.578% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1859.336% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -7225.019% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -198.554% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -8309.972% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3906.925% |
| United Therapeutics Corporation | 1.18 Billion USD | 58.839% |
| HilleVax, Inc. | 78.9 Million USD | -516.661% |
| Silo Pharma, Inc. | 1.56 Million USD | -30908.112% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -36334.121% |
| Pharming Group N.V. | 244.07 Million USD | -99.367% |
| Tharimmune, Inc. | 1.81 Million USD | -26709.293% |
| Genprex, Inc. | 3.25 Million USD | -14852.978% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2164.208% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1694.318% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -913.288% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -236114.078% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -135614.326% |
| OKYO Pharma Limited | 7.42 Million USD | -6457.217% |
| Savara Inc. | 37.19 Million USD | -1208.349% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1577.067% |
| Curis, Inc. | 57.61 Million USD | -744.617% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1141.336% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2237.293% |
| BeiGene, Ltd. | 2.23 Billion USD | 78.216% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2187.304% |
| Erasca, Inc. | 78.61 Million USD | -518.999% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -74161.658% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -74161.658% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -6856.412% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -29284.118% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2750.621% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1234.762% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -774.631% |
| Adicet Bio, Inc. | 37.12 Million USD | -1210.886% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 21.224% |
| Aditxt, Inc. | 28.53 Million USD | -1605.483% |
| Adagene Inc. | 45.16 Million USD | -977.282% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -269185.173% |
| Quantum-Si incorporated | 26.63 Million USD | -1727.198% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -15893.785% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -323.275% |
| Compugen Ltd. | 55.77 Million USD | -772.436% |
| Generation Bio Co. | 171.63 Million USD | -183.517% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4112.996% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1063.255% |
| Invivyd, Inc. | 51.71 Million USD | -840.965% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -429.046% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -7380.126% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -544.539% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -47559.256% |
| 2seventy bio, Inc. | 310.12 Million USD | -56.904% |
| Instil Bio, Inc. | 99.8 Million USD | -387.571% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1246.699% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -35604.873% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13724.359% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3895.193% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3890.234% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -820.878% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -31.566% |
| Evaxion Biotech A/S | 17.61 Million USD | -2662.035% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -202.37% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -217.654% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2153.304% |
| Cingulate Inc. | 10.36 Million USD | -4596.529% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -17594.582% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1204.84% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1858.232% |
| Clearmind Medicine Inc. | 3.61 Million USD | -13379.222% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -934.375% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2037.991% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2324.398% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -106.876% |
| ImmunityBio, Inc. | 1.09 Billion USD | 55.374% |
| Korro Bio, Inc. | 51.75 Million USD | -840.255% |
| Kineta, Inc. | 7.22 Million USD | -6637.76% |
| BioVie Inc. | 9.7 Million USD | -4915.404% |
| Codexis, Inc. | 49.94 Million USD | -874.254% |
| Celularity Inc. | 102.92 Million USD | -372.754% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -332.923% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -405.575% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -140864.501% |
| Cibus, Inc. | 206.11 Million USD | -136.08% |
| IN8bio, Inc. | 8.77 Million USD | -5447.207% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -443.439% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -3454.686% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 81.309% |
| Eyenovia, Inc. | 19.78 Million USD | -2360.031% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -174.782% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6235.126% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1319.407% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1919.175% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3989.771% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -98.176% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4988.372% |
| Moolec Science SA | 13.94 Million USD | -3389.341% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1027.644% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -862.956% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1123.353% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -5736.644% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -165182.297% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -19678.261% |
| Humacyte, Inc. | 114.67 Million USD | -324.323% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1738.798% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -40585.702% |
| Genelux Corporation | 8.42 Million USD | -5679.109% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -6997.447% |
| Notable Labs, Ltd. | 4.42 Million USD | -10891.665% |
| Immunovant, Inc. | 48.95 Million USD | -893.976% |
| Quantum-Si incorporated | 26.63 Million USD | -1727.198% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -15581.631% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -558.806% |
| Acasti Pharma Inc. | 11.55 Million USD | -4110.444% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2052.366% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1998.866% |
| PepGen Inc. | 34.63 Million USD | -1305.102% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -6867.368% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5586.456% |
| Immuneering Corporation | 12 Million USD | -3952.187% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -154938.584% |
| Belite Bio, Inc | 4.21 Million USD | -11455.474% |
| XOMA Corporation | 145.58 Million USD | -234.25% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -19941.227% |
| Bionomics Limited | 10.15 Million USD | -4689.983% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2023.69% |
| uniQure N.V. | 624.01 Million USD | 22.021% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -269185.173% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -185.926% |
| Forte Biosciences, Inc. | 3.66 Million USD | -13173.35% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -186635.512% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -7112.109% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6235.126% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2699.292% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -4504.476% |
| Altimmune, Inc. | 16.54 Million USD | -2841.787% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -9883.607% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2023.69% |
| Peak Bio, Inc. | 20.75 Million USD | -2244.685% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -340.51% |
| Benitec Biopharma Inc. | 4.96 Million USD | -9706.55% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -208.282% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -547.3% |
| Zura Bio Limited | 21.29 Million USD | -2185.37% |
| PolyPid Ltd. | 17.46 Million USD | -2685.671% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -547.3% |
| argenx SE | 444.95 Million USD | -9.361% |
| Immunome, Inc. | 28.65 Million USD | -1597.959% |
| Verona Pharma plc | 58.84 Million USD | -726.976% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3262.129% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3174.79% |
| CervoMed Inc. | 2.59 Million USD | -18646.087% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3720.674% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -4518.899% |
| Moolec Science SA | 13.94 Million USD | -3389.341% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -20663.822% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3969.931% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3736.337% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1150.003% |
| Achilles Therapeutics plc | 19.08 Million USD | -2449.384% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2037.991% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3253.325% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -21.264% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1398.479% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -3629.002% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -9163.297% |
| Beam Therapeutics Inc. | 478.38 Million USD | -1.717% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -22.277% |
| AEON Biopharma, Inc. | 159.88 Million USD | -204.337% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1687.135% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1774.354% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -6300.778% |
| NeurAxis, Inc. | 1.91 Million USD | -25340.01% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -148.598% |
| Lumos Pharma, Inc. | 13.33 Million USD | -3549.599% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1962.918% |
| Palisade Bio, Inc. | 2.73 Million USD | -17665.644% |
| Nutriband Inc. | 1.07 Million USD | -45000.791% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -153.363% |
| Neurogene Inc. | 36.54 Million USD | -1231.366% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -19801.881% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -921.198% |
| Athira Pharma, Inc. | 30.05 Million USD | -1518.927% |
| HCW Biologics Inc. | 15.05 Million USD | -3132.812% |
| XOMA Corporation | 145.58 Million USD | -234.25% |
| Nektar Therapeutics | 267.04 Million USD | -82.216% |
| Arvinas, Inc. | 644.6 Million USD | 24.511% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2644.022% |
| Merus N.V. | 102.15 Million USD | -376.355% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -232.491% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -411.565% |
| Rezolute, Inc. | 11.73 Million USD | -4046.932% |
| Clene Inc. | 38.95 Million USD | -1149.264% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -16989.43% |
| BeyondSpring Inc. | 48.26 Million USD | -908.103% |
| Synlogic, Inc. | 32.89 Million USD | -1379.255% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3229.919% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -29679.743% |
| Peak Bio, Inc. | 20.75 Million USD | -2244.685% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -666.796% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1125.263% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -29.194% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -388.707% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -112350.142% |
| MannKind Corporation | 721.36 Million USD | 32.545% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2078.648% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -23226.989% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -374.316% |
| Gossamer Bio, Inc. | 249.14 Million USD | -95.307% |
| CohBar, Inc. | 1.03 Million USD | -46976.539% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -4452.353% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2454.604% |
| Legend Biotech Corporation | 589.93 Million USD | 17.516% |
| Mural Oncology plc | 37.92 Million USD | -1182.96% |
| Disc Medicine, Inc. | 22.87 Million USD | -2027.217% |
| Champions Oncology, Inc. | 28.03 Million USD | -1635.691% |
| REGENXBIO Inc. | 262.22 Million USD | -85.564% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -14384.966% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3782.248% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -3522.8% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2194.747% |
| Vaxart, Inc. | 34.02 Million USD | -1330.128% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2286.555% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1605.464% |
| Cellectis S.A. | 249.57 Million USD | -94.972% |
| Longeveron Inc. | 5.33 Million USD | -9017.5% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1063.588% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 79.769% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -706.058% |
| Revolution Medicines, Inc. | 262.39 Million USD | -85.445% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -22994.495% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -5541.097% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4023.388% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3365.079% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -22522.083% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 90.551% |
| Denali Therapeutics Inc. | 122.96 Million USD | -295.73% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8644.12% |
| Veru Inc. | 32.81 Million USD | -1382.965% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -6984.015% |
| Cingulate Inc. | 10.36 Million USD | -4596.529% |
| Passage Bio, Inc. | 39.26 Million USD | -1139.369% |
| Context Therapeutics Inc. | 4.19 Million USD | -11508.638% |
| Exicure, Inc. | 8.54 Million USD | -5591.905% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1549.048% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -4540.483% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2107.708% |
| Nuvalent, Inc. | 31.82 Million USD | -1429.086% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -7549.002% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -672.113% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2603.339% |
| OmniAb, Inc. | 87.4 Million USD | -456.752% |
| Anew Medical, Inc. | 8.24 Million USD | -5804.063% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1170.861% |
| Lipocine Inc. | 2.63 Million USD | -18390.486% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1752.166% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1110.089% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1726.456% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -464.804% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -8909.461% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -488.059% |
| Ocugen, Inc. | 23.98 Million USD | -1928.941% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -948.551% |
| Q32 Bio Inc. | 233.12 Million USD | -108.727% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -5267.317% |
| Alumis Inc. Common Stock | 53.5 Million USD | -809.501% |
| Equillium, Inc. | 27.95 Million USD | -1640.534% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -135.537% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -8548.125% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -7834.185% |
| Dominari Holdings Inc. | 4.63 Million USD | -10398.403% |
| Edesa Biotech, Inc. | 1.84 Million USD | -26322.199% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1545.757% |
| Bio-Techne Corporation | 744.34 Million USD | 34.627% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -285.888% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -41.267% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1099.263% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1580.426% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -426.853% |
| Nkarta, Inc. | 105.6 Million USD | -360.796% |
| BioCardia, Inc. | 4.59 Million USD | -10501.329% |
| Iterum Therapeutics plc | 32.66 Million USD | -1389.808% |